Literature DB >> 15210653

Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension.

Paolo Palatini1, Mikolaj Winnicki, Massimo Santonastaso, Lucio Mos, Daniele Longo, Vania Zaetta, Marta Dal Follo, Tiziano Biasion, Achille C Pessina.   

Abstract

Little is known about the clinical significance of isolated ambulatory hypertension, a condition characterized by low office but elevated ambulatory blood pressure. This study aimed to investigate the prevalence and the predictive value of isolated ambulatory hypertension diagnosed after 3 months of observation for the development of sustained hypertension within a cohort of 871 never-treated stage-1 hypertensive subjects. The study end point was progression to more severe hypertension and need of antihypertensive medication. In 244 subjects (28%), clinic blood pressure declined to <140/90 mm Hg after 3 months. Of these, 124 (14.2% of total) had low clinic and ambulatory blood pressures after 3 months (nonhypertensive subjects), whereas 120 subjects (13.8% of total) showed low clinic but elevated ambulatory blood pressure (isolated ambulatory hypertension). During the 6 years of observation, the number of end points based on multiple clinic blood pressure readings progressively increased from the nonhypertensive subjects (19%) to the subjects with isolated ambulatory hypertension (35%) and to the subjects with high clinic and high ambulatory blood pressures (65%, P<0.0001). In an adjusted proportional hazard model, isolated ambulatory hypertension status was associated with a 2.2 (P=0.02) increase in the risk of reaching the end point in comparison with the nonhypertensive subjects. Final ambulatory systolic blood pressure was also higher in the former than the latter (P=0.03). Our results indicate that among subjects screened for stage 1 hypertension, individuals with isolated ambulatory hypertension after 3 months of observation have increased risk of developing sustained hypertension in later life compared with subjects in whom both clinic and ambulatory blood pressures are normal.

Entities:  

Mesh:

Year:  2004        PMID: 15210653     DOI: 10.1161/01.HYP.0000135250.57004.19

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

Review 1.  Masked hypertension: a common but insidious presentation of hypertension.

Authors:  D W McKay; Martin G Myers; Peter Bolli; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

2.  Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study.

Authors:  Daichi Shimbo; Jonathan D Newman; Joseph E Schwartz
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

Review 3.  How should we manage a patient with masked hypertension?

Authors:  Paolo Palatini
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-06

4.  Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study.

Authors:  Marwah Abdalla; John N Booth; Samantha R Seals; Tanya M Spruill; Anthony J Viera; Keith M Diaz; Mario Sims; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2016-05-16       Impact factor: 10.190

5.  Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study.

Authors:  Paolo Palatini; Gianpaolo Reboldi; Lawrence J Beilin; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Francesca Saladini; Joseph E Schwartz; Lindon Wing; Paolo Verdecchia
Journal:  Int J Cardiol       Date:  2013-02-08       Impact factor: 4.164

6.  Franz Volhard lecture: should doctors still measure blood pressure? The missing patients with masked hypertension.

Authors:  Thomas G Pickering; William Gerin; Joseph E Schwartz; Tanya M Spruill; Karina W Davidson
Journal:  J Hypertens       Date:  2008-12       Impact factor: 4.844

7.  Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study.

Authors:  Gianpaolo Reboldi; Paolo Verdecchia; Francesca Saladini; Marina Pane; Lawrence J Beilin; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Joseph E Schwartz; Lindon Wing; Paolo Palatini
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

8.  Prognostic Value of Ambulatory Blood Pressure in the Obese: The Ambulatory Blood Pressure-International Study.

Authors:  Paolo Palatini; Gianpaolo Reboldi; Lawrence J Beilin; Edoardo Casiglia; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Joseph E Schwartz; Lindon Wing; Paolo Verdecchia
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-05       Impact factor: 3.738

Review 9.  The natural history of hypertension: prehypertension or masked hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

Review 10.  Masked hypertension definition, impact, outcomes: a critical review.

Authors:  Dimitris P Papadopoulos; Thomas K Makris
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.